 Effect verapamil mortality major events acute myocardial infarction Danish Verapamil Infarction Trial II DAVIT II effect verapamil death major events death reinfarction acute myocardial infarction double-blind placebo-controlled multicenter trial seventy-eight patients treatment verapamil mg/day patients placebo Treatment second week admission months mean months Ninety-five deaths major events verapamil group deaths major events placebo group mortality rates hazard ratio confidence limits major event rates hazard ratio confidence limits verapamil placebo groups patients heart failure coronary care unit mortality rates verapamil group placebo group hazard ratio confidence limits major event rates confidence limits patients heart failure mortality rates hazard ratio confidence limits major event rates confidence Long-term treatment verapamil acute myocardial infarction significant reduction major events positive effect patients heart failure